Treatment of Infantile Hemangiomas with Sirolimus in a Patient with PHACE Syndrome

Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma

(2011) Shoshana Greenberger et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling

(2011) W van Veelen et al.   ONCOGENE

Sirolimus for the treatment of complicated vascular anomalies in children

(2011) Adrienne M. Hammill et al.   PEDIATRIC BLOOD & CANCER

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

Update on vascular tumors of infancy

(2010) Robert Sidbury   CURRENT OPINION IN PEDIATRICS

Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells

(2010) Shoshana Greenberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of childhood kaposiform hemangioendothelioma with sirolimus

(2010) Julie Blatt et al.   PEDIATRIC BLOOD & CANCER